|
Characteristic
|
Na (%)
|
CA125b (U/ml)
|
Albumin b (g/l)
|
Leukocyte differential counts b (k/μl)
|
Platelet b (k/μl)
|
D-dimer b (mg/l)
|
Ratio b
|
|---|
|
Lymphocyte
|
Monocyte
|
Neutrophil
|
NLR
|
MLR
|
PLR
|
|---|
|
All cases
|
84
|
187.9 (6.5–5000*)
|
40.7 (25.9–52.1)
|
1.5 (0.4–2.9)
|
0.4 (0.03–1.6)
|
4.1 (1.9–15.2)
|
299 (124–608)
|
1.66 (0.19–55.20)
|
2.7 (1.1–20.3)
|
0.28 (0.03–2.00)
|
193.9 (77.5–955.0)
|
|
Age (years)
|
|
≤ 52
|
42 (50)
|
188.0 (6.5–2854)
|
40.7 (33.1–49.4)
|
1.5 (0.6–2.9)
|
0.4 (0.2–1.0)
|
4.0 (1.9–12.2)
|
301 (124–500)
|
1.66 (0.19–55.20)
|
2.6 (1.1–20.3)
|
0.25 (0.12–0.83)
|
201.7 (77.5–615.0)
|
|
> 52
|
42 (50)
|
165.0 (11.1–5000*)
|
40.4 (25.9–52.1)
|
1.5 (0.4–2.4)
|
0.4 (0.03–1.6)
|
4.4 (1.9–15.2)
|
296 (147–608)
|
1.66 (0.20–20.00)
|
2.8 (1.1–20.3)
|
0.32 (0.03–2.00)
|
191.0 (92.1–955.0)
|
|
P value
| |
0.589
|
0.056
|
0.874
|
0.039
|
0.826
|
0.871
|
0.756
|
0.826
|
0.053
|
0.940
|
|
FIGO stage
|
|
IC-II
|
47 (56.0)
|
70.5 (6.5–1930.0)
|
43.6 (29.6–52.1)
|
1.5 (0.9–2.9)
|
0.4 (0.03–1.0)
|
3.6 (1.9–10.7)
|
292 (124–500)
|
1.49 (0.19–55.20)
|
2.2 (1.1–7.1)
|
0.21 (0.03–0.67)
|
167.5 (77.5–500.0)
|
|
III-IV
|
37 (44.0)
|
276.9 (45.6–5000*)
|
39.2 (25.9–49.2)
|
1.4 (0.4–2.4)
|
0.4 (0.3–1.6)
|
4.6 (1.9–15.2)
|
311 (147–608)
|
2.61 (0.69–11.03)
|
3.2 (1.1–20.3)
|
0.33 (0.18–2.00)
|
230.0 (101.7–955.0)
|
|
P value
| |
< 0.001
|
< 0.001
|
0.031
|
0.002
|
0.009
|
0.320
|
0.001
|
0.001
|
< 0.001
|
0.006
|
|
Residual tumor (cm)
|
|
0
|
63 (75.0)
|
157.4 (6.5–5000*)
|
41.7 (28.3–52.1)
|
1.5 (0.6–2.9)
|
0.4 (0.03–1.6)
|
3.8 (1.9–15.2)
|
292 (124–608)
|
1.66 (0.19–55.20)
|
2.4 (1.1–7.1)
|
0.25 (0.03–0.70)
|
173.5 (77.5–500)
|
|
≤ 1
|
14 (16.7)
|
371.4 (45.6–1845.3)
|
38.4 (29.0–43.7)
|
1.4 (0.9–2.4)
|
0.5 (0.3–0.9)
|
4.7 (2.7–6.6)
|
318 (202–593)
|
2.53 (0.69–9.30)
|
3.2 (1.3–5.7)
|
0.35 (0.19–0.82)
|
219.8 (107.1–539.1)
|
|
> 1
|
7 (8.3)
|
475.1 (151.6–1866.0)
|
33.2 (25.9–49.2)
|
0.9 (0.4–1.8)
|
0.6 (0.3–1.4)
|
8.1 (2.7–12.2)
|
342 (253–382)
|
3.29 (0.75–6.06)
|
8.2 (2.8–20.3)
|
0.67 (0.39–2.00)
|
383.3 (190.0–955.0)
|
|
P value
| |
0.007
|
0.006
|
0.008
|
0.002
|
0.005
|
0.314
|
0.064
|
< 0.001
|
< 0.001
|
0.004
|
|
Platinum response
|
|
Sensitive
|
58 (69.0)
|
124.6 (6.47–5000*)
|
41.7 (29.0–52.1)
|
1.5 (0.6–2.9)
|
0.4 (0.03–1.0)
|
3.8 (1.9–10.7)
|
279 (124–500)
|
1.66 (0.19–20.00)
|
2.4 (1.1–7.1)
|
0.25 (0.03–0.70)
|
176.7 (77.5–500.0)
|
|
resistant
|
24 (28.6)
|
294.3 (38.21–1866.0)
|
39.2 (25.9–49.2)
|
1.5 (0.4–2.4)
|
0.5 (0.2–1.6)
|
4.9 (2.1–15.2)
|
316 (202–608)
|
3.82 (0.44–55.20)
|
3.2 (1.1–20.3)
|
0.35 (0.15–2.00)
|
214.3 (126.3–955.0)
|
|
P value
| |
0.002
|
0.012
|
0.400
|
0.011
|
0.003
|
0.157
|
< 0.001
|
0.002
|
0.004
|
0.060
|
- Abbreviations: SIR systemic inflammatory response, NLR neutrophil to lymphocyte ratio, MLR monocyte to lymphocyte ratio, PLR platelet to lymphocyte ratio
- P values with statistical significance were denoted
- a Categorical data are shown in absolute value and proportion
- b Continuous variables are represented by median and range
- * The upper limit of CA125 detection is 5000
